Frequency of dual infections of corneas with HIV-1 and HHV-6

References

• Salahuddin S. Z., Palestine A. G., Heck E. Isolation of human T-cell leukemia/lymphotrophic virus type III from cornea. Am. J. Ophthalmol. 1986; 101: 149–152
   PubMed Web of Science ®Google Scholar
• Ablashi D. V., Sturzenegger S., Hunter E. A., Palestine A. G., Fujikawa L. S., Kim M. K., Nussenblatt R. B., Markham P. D., Salahuddin S. Z. Presence of HTLV-III in tears and cells from the eyes of AIDS patients. J. Exp. Pathol. 1987; 3: 693–703
   PubMedGoogle Scholar
• Doro S., Navia B. A., Kahn A., Pumarola-Sune T., Price R. W. Confirmation of HTLV-III virus in cornea. Am. J. Ophthalmol. 1987; 102: 390–391
   Web of Science ®Google Scholar
• Cantrill H. L., Henry K., Jackson G., Erice A., Ussery F. M., Balfour H. H. Recovery of human immunodeficiency virus from ocular tissues in patients with acquired immune deficiency syndrome. Ophthalmology 1988; 95: 1458–1462
   PubMed Web of Science ®Google Scholar
• Qavi H. B., Green M. T., SeGall G. K., Hollinger F. B., Lewis D. E. The incidence of HIV-1 and HHV-6 in corneal buttons. Curr. Eye. Res. 1991; 10: 97–103, Suppl
   PubMed Web of Science ®Google Scholar
• Pepose J. S., MacRae S., Quinn T. C., Holland G. N. The impact of the AIDS epidemic on corneal transplantation. Am. J. Ophthalmol. 1985; 103: 610–613
   Google Scholar
• Pepose J. S., MacRae S., Quinn T. C., Ward J. W. Serologic markers after the transplantation of corneas from donors infected with human immunodeficiency virus. Am. J. Ophthalmol. 1987; KB: 798–801
   Google Scholar
• Burnett W. N. “Western Blottin”: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 1981; 112: 195–203
   PubMed Web of Science ®Google Scholar
• Fung M. S.C., Sun C., Sun N. C., Chang N T., Chang T. W. Monoclonal antibodies that neutralize HIV-1 virions and inhibit syncytium formation by infected cells. Bio/Technology 1987; 5: 940–946
   Google Scholar
• Qavi H. B., Green M. T., SeGall G. K., Font R. L. Demonstration of HIV-1 and HHV-6 in AIDS-associated retinitis. Curr. Eye Res. 1989; 8: 379–387
   PubMed Web of Science ®Google Scholar
• Harper M. E., Marselle L. M., Gallo R. C., Wong-Staal F. Detection of lymphocyte expressing human T-lymphocyte virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc. Natl. Acad. Sci., USA 1986; 83: 772–777
   PubMed Web of Science ®Google Scholar
• Lewis D. E., Wray N. L., Smith L. C., Grave M. M. Confocal microscopic detection of human immunodeficiency virus RNA producing cells. J. Infec. Dis. 1990; 162: 1373–1378
   Google Scholar
• Yoffe B., Petrie B. L., Noonan C. A., Hollinger F. B. In vivo and in vitro ultrastructural alterations induced by human immunodeficiency virus in human lymphoid cells. Lab. Invest. 1989; 61: 303–309
   PubMed Web of Science ®Google Scholar
• Southern E. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 1975; 98: 503–517
   PubMed Web of Science ®Google Scholar
• Haseltine W. A., Wong-Staal F. The molecular biology of the AIDS virus. Sci. Amer-Octoher 1988; 52–62
   Google Scholar
• Font R. L., Keener M. J., Holback L. M. Tubuloreticular structures (TRS) in endothelial cells of retinal vessels and choriocapillaries as a marker for AIDS. Invest. Opth. Vis. Sci. 1990; 31: 169, Suppl
   Google Scholar
• Daskal Y., Schmidt W. A., Bretaudiere J. P., Gyorkey F., Hollinger F. B. Ultrastructural analysis of cytoplasmic inclusions of lymph node leukocytes of AIDS patients and experimentally induced NANBH type III cylindric complexes. Am. J. Clin. Pathol. 1985; 83: 270
   Web of Science ®Google Scholar
• Kostianovsky M., Grimley P. M. Ultrastructural findings in the acquired immunodeficiency syndrome (AIDS), Ultrastruct. Pathol. 1985; 8: 123–131
   Web of Science ®Google Scholar
• Onerheim R. M., Wang N. S., Gilmore N., Jothy S. Ultrastructural markers of lymph nodes in patients with acquired immune deficiency syndrome and in homosexual males with unexplained persistent lymphadenopathy. A Quantitative study. Am. J. Clin. Pathol. 1984; S2: 280–289
   Google Scholar
• Mosca J. D., Bednarik D. P., Raj N. B.K., Rosen C. A., Sodroski J. G., Haseltine W. A., Hayward G. S., Pitha P. M. Activation of human immunodeficiency virus by herpesvirus infection: Identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1. Proc. Natl. Acad. Sci., USA 1987; 84: 7408–7412
   PubMedGoogle Scholar
• Mosca J. D., Bednarik D. P., Raj N. B.K., Rosen C. A., Sodroski J. G., Haseltine W. A., Pitha P. M. Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus. Nature 1987; 326: 711–713
   Google Scholar
• Davis M. G., Kenney S. C., Kamine J., Pagano J. S., Huang E. S. Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. Proc. Natl. Acad. Sci., USA 1987; 84: 8642–8646
   PubMed Web of Science ®Google Scholar
• Nelson J. A., Reynolds-Kohler C., Oldstone M. B.A., Wiley C. A. HIV and HCMV coinfect brain cells in patients with AIDS. Virology 1989; 165: 286–290
   Google Scholar
• Paya C. V., Virelizier J.-L., Michelson S. Modulation of T-cell activation through protein kinase C- or A-dependent signalling pathways synergistically increases human immunodeficiency virus long terminal repeat induction by cytomegalovirus immediate-early proteins. J. Virol. 1991; 65: 5477–5484
   PubMedGoogle Scholar
• Kenney S., Kamine J., Markovitz D., Fenrick R., Pagano J. An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat. Proc. Natl. Acad. Sci., USA 1988; 85: 1652–1656
   Google Scholar
• Ensoli B., Lusso P., Schachter F., Josephs S. F., Rappaport J., Negro F., Gallo R. C., Wong-Staal F. Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer. EMBOJ. 1989; 8: 3019–3027
   PubMed Web of Science ®Google Scholar
• Gallo R., Lusso P., Salahuddin S. Z. Herpesvirus in pathogenesis of AIDS. JAMA 1989; 26 L: 2481
   Google Scholar
• Lusso P., Ensoli B., Markham P. D., Ablashi D. V., Salahuddin S. Z., Tschachler E., Wong-Staal F., Gallo R. C. Productive dual infection of human CD4+ T-lymphocytes by HIV-1 and HHV-6. Nature 1989; 337: 370–373
   PubMed Web of Science ®Google Scholar
• Lusso P., Markham P. D., DeRocco S. E., Gallo R. C. In vitro susceptibility of T-lymphocytes from chimpanzees (Pan Troglodytes) to human herpesvirus 6 (HHV-6): a potential animal model to study the interaction between HHV-6 and human immunodeficiency virus type 1 in vivo. J. Virol. 1990; 64: 2751–2758
   Google Scholar
• Horvat R. T., Wood C., Josephs S. F., Balachandran N. Transactivation of the human immunodeficiency virus promoter by human herpesvirus 6 (HHV-6) strains GS and Z-29 in primary human T lymphocytes and identification of transactivating HHV-6(GS) gene fragments. J. Virol. 1991; 65: 2895–2902
   PubMed Web of Science ®Google Scholar
• Lopez C., Pellett P., Stewart J., Goldsmith C., Sanderlin K., Black J., Warfield D., Feorino P. Characteristics of human herpesvirus-6. J. Infect. Dis. 1988; 157: 1271–1273
   PubMed Web of Science ®Google Scholar
• Martin M. E.D., Nicholas J., Thomson B. J., Newman C., Honess R. W. Identification of a transactivating function mapping to the putative immediate-early locus of human herpesvirus 6. J. Virol. 1991; 65: 5381–5390
   Google Scholar
• Carrigan D. R., Knox K. K., Tapper M. A. Suppression of human immunodeficiency virus type 1 replication by human herpesvirus-6. J. Infect. Dis. 1990; 162: 844–851
   PubMed Web of Science ®Google Scholar